Mechanisms of Disease: temozolomide and glioblastoma—look to the future-Reference-Cited by-同舟云学术

Mechanisms of Disease: temozolomide and glioblastoma—look to the future

Published:2008-06-10 Issue:8 Volume:5 Page:476-486
ISSN:1743-4254
Container-title:Nature Clinical Practice Oncology
language:en
Short-container-title:Nat Rev Clin Oncol

Author:

Mrugala Maciej M,Chamberlain Marc C

Publisher

Springer Science and Business Media LLC

Subject

Oncology,General Medicine

Link

http://www.nature.com/articles/ncponc1155.pdf

Reference79 articles.

1. Central Brain Tumor Registry of the United States (CTBRUS) Report 2004. [ http://www.cbtrus.org/factsheet/factsheet.html ] (Accessed 18 April 2008)

2. Stupp R et al. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987–996

3. Stupp R et al. (2002) Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol 20: 1375–1382

4. Mirimanoff RO et al. (2006) Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. J Clin Oncol 24: 2563–2569

5. Esteller M et al. (2000) Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 343: 1350–1354

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modelling glioblastoma resistance to temozolomide. A mathematical model to simulate cellular adaptation in vitro;Computers in Biology and Medicine;2024-09

2. Oral Delivery of Photoresponsive Milk-Derived Exosomes for the Local Therapy of Glioblastoma;ACS Materials Letters;2024-07-31

3. Gene expression profiling and the isocitrate dehydrogenase mutational landscape of temozolomide‑resistant glioblastoma;Oncology Letters;2024-06-17

4. Overcoming the Blood–Brain Tumor Barrier with Docetaxel-Loaded Mesoporous Silica Nanoparticles for Treatment of Temozolomide-Resistant Glioblastoma;ACS Applied Materials & Interfaces;2024-04-17

5. Microneedle Patch Delivery of PLCG1-siRNA Efficient Enhanced Temozolomide Therapy for Glioblastoma;Biomacromolecules;2024-01-19